Repligen Corporation Banner Image

Repligen Corporation

  • Ticker RGEN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Repligen Corporation Logo Image
  • 201-500 Employees
  • Based in Waltham, Massachusetts
Repligen Corporation (NASDAQ:RGEN) is a bioprocessing company focused on the development, manufacture and commercialization of highly innovative products used to improve the interconnected phases of the biological drug manufacturing process. Repligen's portfolio includes protein products (Protein A affinity ligands, cell culture growth factors), chromatography products (OPUS® pre-packedMore columns, chromatography resins, ELISA kits) and filtration products (XCell™ ATF Systems, TangenX™ Sius™ TFF cassettes). The company's bioprocessing products are sold to major life sciences companies, biopharmaceutical development companies and contract manufacturing organizations worldwide.
Repligen Corporation

Most Recent Annual Report

Repligen Corporation MOST RECENT 2019 Annual Report and Form 10K

Older/Archived Annual Reports